Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) shares gapped down prior to trading on Tuesday . The stock had previously closed at $20.93, but opened at $19.84. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $20.32, with a volume of 40,699 shares traded.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the company. UBS Group raised their price target on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a report on Monday, January 27th. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th.
Read Our Latest Stock Analysis on TLX
Telix Pharmaceuticals Limited American Depositary Shares Stock Performance
About Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
Featured Stories
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- How to Invest in Small Cap Stocks
- Home Depot Turns a Corner: New Highs Likely This Year
- The How And Why of Investing in Oil Stocks
- February’s Top 3 Stock Upgrades: What Investors Need to Know
- The Basics of Support and Resistance
- 2 Safe-Haven Stocks Shielded From Import Tariffs
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
